Abstract
Abstract
Background
Freshwater snails of the genera Bulinus spp., Biomphalaria spp., and Oncomelania spp. are the main intermediate hosts of human and animal schistosomiasis. Identification of these snails has long been based on morphological and/or genomic criteria, which have their limitations. These limitations include a lack of precision for the morphological tool and cost and time for the DNA-based approach. Recently, Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI–TOF) mass spectrometry, a new tool used which is routinely in clinical microbiology, has emerged in the field of malacology for the identification of freshwater snails. This study aimed to evaluate the ability of MALDI–TOF MS to identify Biomphalariapfeifferi and Bulinusforskalii snail populations according to their geographical origin.
Methods
This study was conducted on 101 Bi.pfeifferi and 81 Bu.forskalii snails collected in three distinct geographical areas of Senegal (the North-East, South-East and central part of the country), and supplemented with wild and laboratory strains. Specimens which had previously been morphologically described were identified by MALDI–TOF MS [identification log score values (LSV) ≥ 1.7], after an initial blind test using the pre-existing database. After DNA-based identification, new reference spectra of Bi.pfeifferi (n = 10) and Bu.forskalii (n = 5) from the geographical areas were added to the MALDI–TOF spectral database. The final blind test against this updated database was performed to assess identification at the geographic source level.
Results
MALDI–TOF MS correctly identified 92.1% of 101 Bi.pfeifferi snails and 98.8% of 81 Bu.forskalii snails. At the final blind test, 88% of 166 specimens were correctly identified according to both their species and sampling site, with LSVs ranging from 1.74 to 2.70. The geographical source was adequately identified in 90.1% of 91 Bi.pfeifferi and 85.3% of 75 Bu.forskalii samples.
Conclusions
Our findings demonstrate that MALDI–TOF MS can identify and differentiate snail populations according to geographical origin. It outperforms the current DNA-based approaches in discriminating laboratory from wild strains. This inexpensive high-throughput approach is likely to further revolutionise epidemiological studies in areas which are endemic for schistosomiasis.
Funder
Département Soutien et Formation, Institut de Recherche pour le Développement
Fondation Méditerranée Infection
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. McManus DP, Bergquist R, Cai P, Ranasinghe S, Tebeje BM, You H. Schistosomiasis—from immunopathology to vaccines. Semin Immunopathol. 2020;42:1–17.
2. OMS. Agir pour réduire l’impact mondial des maladies tropicales négligées: premier rapport de l’OMS sur les maladies tropicales négligées : résume. 2010. https://iris.who.int/handle/10665/70754. Accessed 11 Nov 2023.
3. Weerakoon KGAD, Gobert GN, Cai P, McManus DP. Advances in the diagnosis of human schistosomiasis. Clin Microbiol Rev. 2015;28:939–67.
4. Tchouanguem HN, Fouelifack FY, Keugoung B, Fouelifa LD, Moyou RS. Situation actuelle de la schistosomiase dans l’aire de santé de Santchou, (District de santé de Santchou, Région de l’Ouest-Cameroun). Pan Afr Med J. 2016;24 (in French).
5. WHO. Schistosomiasis and soil-transmitted helminthiases: progress report, 2021 WER 48. 2022;97:621–32. https://iris.who.int/bitstream/handle/10665/364997/WER9748-eng-fre.pdf?sequence=1. Accessed 11 Nov 2023.